Status:
RECRUITING
Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
University of the Italian Switzerland
Clinical Trial Unit, University Hospital Basel, Switzerland
Conditions:
Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
Intravitreal dyes are intended to make the surgical extraction of the Internal limiting membrane (ILM) safer and more complete. However, the search for an adequate vitaly dye is ongoing. The most comm...
Detailed Description
The human retina is a light-sensitive tissue lining the inner surface of the posterior segment of the eye. It is a complex, layered structure containing the photoreceptors and several layers of neuron...
Eligibility Criteria
Inclusion
- Over 18 Years of age
- No other chromovitrectomy in previous 6 months
- Only one of three vitaly dyes used intraoperatively (BBG, ICG or TB)
Exclusion
- Previous chromovitrectomy during last 6 months
- Pregnant patients
- Patients under 18 years of age
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01485575
Start Date
November 1 2011
End Date
June 1 2028
Last Update
February 13 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital Linz
Linz, Austria, 4010
2
St. Gallen Hospital
Sankt Gallen, Canton of St. Gallen, Switzerland, 9007
3
Oftacentro
Paradiso, Canton Ticino, Switzerland, 6900